Preparing for change & workable solutions & clarifying complexity & poachers turned gamekeepers & different perspectives & shaping the rules & that’s Regulatory & Administrative with Bird & Bird
Our Regulatory & Administrative Practice helps domestic and international businesses, banks, financial institutions and a wide range of other organisations achieve maximum benefit from their dealings with regulatory bodies and national, regional or local governments.
We advise on cutting edge regulatory and competition issues, from the perspectives of universal service providers and other, new entrant operators.
We can also help you prepare for regulatory changes, manage your relationships with regulators and, where possible, help you to achieve regulatory change or clarification. We advise on licensing issues; business strategy in the light of regulatory requirements; and the approaches of regulatory authorities, both at EU level and at national levels across Europe and Asia. We represent clients as defendants, complainants or interveners in regulatory and competition regulatory investigations by EU and national authorities.
Our approach, whilst founded on an in-depth understanding of the legal and regulatory landscape, has a strongly practical and commercial focus. We give clear explanations of complex issues, robustly promote and defend your interests and add value wherever possible to your business.
We provide expertise in the following:
On 3 April 2020, the Ministry of Trade and Industry in Singapore (“MTI”) announced an unprecedented order requiring all non-essential business premises to close effective 7 April 2020.
Hoaxes about the supposed benefits of anti-inflammatory drugs, drinking chloroquine, taking vitamin C or eating garlic soup: these are just a few examples of the type of online misinformation that has been circulating ...
In the midst of the COVID-19 crisis, telecoms operators are faced with significant challenges, including: traffic growth, congestion, network continuity & security issues. On 31 March, the industry association GSMA, ...
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes
There are no forthcoming events for this area. Please click on the button below to view past events.
As #COVID19 continues to shake businesses worldwide, our international Retail & Consumer lawyers have prepared a nu… https://t.co/RXcpuiZ9mM
Telecoms operators are faced with significant challenges during #COVID19 and governments and national regulatory au… https://t.co/KQUK7i9KF4